Status:
UNKNOWN
Outcome of Patients With Primary Aldosteronism
Lead Sponsor:
Changi General Hospital
Collaborating Sponsors:
Singapore General Hospital
Conditions:
Primary Aldosteronism
Primary Aldosteronism Due to Aldosterone Producing Adenoma
Eligibility:
All Genders
14-100 years
Brief Summary
Majority of patients with hypertension have primary hypertension (without an underlying cause). Primary aldosteronism (PA) is the most common cause of secondary hypertension, and can be found in 5-10%...
Eligibility Criteria
Inclusion
- Patients with suspected primary aldosteronism
Exclusion
- Nil
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04428827
Start Date
October 1 2016
End Date
July 30 2022
Last Update
August 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore, 529889